Nabp-logo
Icon-eprofile e-Profile Login and ID Quick Search
home about programs publications news meetings contact
boards of pharmacy members pharmacists students technicians government affairs consumers

New Tamper Resistant Oxycodone Product Approved

June 30, 2011 8:51 am

FDA has approved OXECTATM Tablets CII, an oxycodone HC1 product that is designed to discourage common methods of tampering associated with opioid abuse and misuse. OXECTA is an immediate-release oxycodone HCl medicine for the management of acute and chronic moderate to severe pain that applies technology designed to discourage tampering. More information is available on the Pharmaceutical & Medical Packaging News Web site.

  • PSM Calls on Internet Ad Networks to Adopt...
  • Main
  • Printed Drug Ads Study Concludes that Form...
Sign up to receive NABP e-News Sign up to receive AWARxE News

News Topics

  • Compounding
  • Controlled substances
  • Counterfeit drugs
  • Buying medicine online
  • Committee and task force reports
  • Continuing education
  • Diversion
  • Education
  • Electronic prescriptions
  • Federal regulations
  • Internet pharmacy
  • Medication collection program disposal
  • Over the counter
  • Patient safety
  • Pharmacies
  • Pharmacists
  • Pharmacy technicians
  • Practitioner prescriber
  • Prescribing authority
  • Prescription drug abuse
  • Prescription label
  • Prescription monitoring program
  • Prescriptions
  • Pseudoephedrine
  • Resolutions
  • Tamper resistant prescription
  • Vaccinations

Archives

  • April 2013 (27)
  • March 2013 (21)
  • February 2013 (20)
  • January 2013 (26)
  • 2012 (303)
  • 2011 (359)
  • 2010 (301)
  • 2009 (189)
  • 2008 (188)
  • 2007 (215)
  • 2006 (164)
  • 2005 (53)
  • 2004 (62)
  • 2003 (43)
  • 2002 (37)
  • 2001 (31)

Copyright © 2013 National Association of Boards of Pharmacy® (NABP®).

  • Resources
  • Terms of Use Statement
  • Privacy Policy
  • Linking Policy
NABP